122 related articles for article (PubMed ID: 17465218)
1. [Methyl-3H]-choline incorporation into MCF-7 cells: correlation with proliferation, choline kinase and phospholipase D assay.
Al-Saeedi F; Smith T; Welch A
Anticancer Res; 2007; 27(2):901-6. PubMed ID: 17465218
[TBL] [Abstract][Full Text] [Related]
2. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
3. Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity.
Lucas L; Hernández-Alcoceba R; Penalva V; Lacal JC
Oncogene; 2001 Mar; 20(9):1110-7. PubMed ID: 11314048
[TBL] [Abstract][Full Text] [Related]
4. Alterations of choline phospholipid metabolism in ovarian tumor progression.
Iorio E; Mezzanzanica D; Alberti P; Spadaro F; Ramoni C; D'Ascenzo S; Millimaggi D; Pavan A; Dolo V; Canevari S; Podo F
Cancer Res; 2005 Oct; 65(20):9369-76. PubMed ID: 16230400
[TBL] [Abstract][Full Text] [Related]
5. RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation.
Glunde K; Raman V; Mori N; Bhujwalla ZM
Cancer Res; 2005 Dec; 65(23):11034-43. PubMed ID: 16322253
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells.
Ramírez de Molina A; Rodríguez-González A; Penalva V; Lucas L; Lacal JC
Biochem Biophys Res Commun; 2001 Jul; 285(4):873-9. PubMed ID: 11467831
[TBL] [Abstract][Full Text] [Related]
7. Changes of phospholipase D activity of rat peritoneal mast cells in degranulation.
Lu YB; Wu M; Zhou HL
Acta Pharmacol Sin; 2004 Jan; 25(1):104-9. PubMed ID: 14704130
[TBL] [Abstract][Full Text] [Related]
8. The anti-aromatase effect of progesterone and of its natural metabolites 20alpha- and 5alpha-dihydroprogesterone in the MCF-7aro breast cancer cell line.
Pasqualini JR; Chetrite G
Anticancer Res; 2008; 28(4B):2129-33. PubMed ID: 18751385
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase D activity in human gastric carcinoma.
Uchida N; Okamura S; Kuwano H
Anticancer Res; 1999; 19(1B):671-5. PubMed ID: 10216475
[TBL] [Abstract][Full Text] [Related]
10. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
Iorio E; Ricci A; Bagnoli M; Pisanu ME; Castellano G; Di Vito M; Venturini E; Glunde K; Bhujwalla ZM; Mezzanzanica D; Canevari S; Podo F
Cancer Res; 2010 Mar; 70(5):2126-35. PubMed ID: 20179205
[TBL] [Abstract][Full Text] [Related]
11. Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3.
Holzapfel K; Müller SA; Seidl C; Grosu AL; Schwaiger M; Senekowitsch-Schmidtke R
Strahlenther Onkol; 2008 Jun; 184(6):319-24. PubMed ID: 18535808
[TBL] [Abstract][Full Text] [Related]
12. Choline kinase inhibition induces the increase in ceramides resulting in a highly specific and selective cytotoxic antitumoral strategy as a potential mechanism of action.
Rodríguez-González A; Ramirez de Molina A; Fernández F; Lacal JC
Oncogene; 2004 Oct; 23(50):8247-59. PubMed ID: 15378008
[TBL] [Abstract][Full Text] [Related]
13. Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy.
Villa AM; Caporizzo E; Papagni A; Miozzo L; Del Buttero P; Grilli MD; Amboldi N; Fazio F; Doglia SM; Giglioni B
Eur J Cancer; 2005 Jul; 41(10):1453-9. PubMed ID: 15913986
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase D and choline kinase: their role in cancer development and their potential as drug targets.
Rodríguez-González A; Ramírez de Molina A; Benítez-Rajal J; Lacal JC
Prog Cell Cycle Res; 2003; 5():191-201. PubMed ID: 14593713
[TBL] [Abstract][Full Text] [Related]
15. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells.
Nimmagadda S; Glunde K; Pomper MG; Bhujwalla ZM
Neoplasia; 2009 May; 11(5):477-84. PubMed ID: 19412432
[TBL] [Abstract][Full Text] [Related]
17. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
[TBL] [Abstract][Full Text] [Related]
18. [methyl-3H]Choline incorporation into MCF7 tumour cells: correlation with proliferation.
Al-Saeedi F; Welch AE; Smith TA
Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):660-7. PubMed ID: 15660258
[TBL] [Abstract][Full Text] [Related]
19. Choline pathways during normal and stimulated renal growth in rats.
Bean GH; Lowenstein LM
J Clin Invest; 1978 Jun; 61(6):1551-4. PubMed ID: 659614
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]